From US$ 2.9 Bn to US$ 10.2 Bn: Strategic Growth Opportunities in the Pancreatic Cancer Treatment Market
The global pancreatic cancer treatment market is poised for significant expansion over the next decade, driven by rising disease incidence, advancements in precision oncology, and increasing investment in targeted and immunotherapeutic approaches. Valued at US$ 2.9 Bn in 2023, the industry is projected to grow at a robust CAGR of 12.4% from 2024 to 2034, reaching an estimated US$ 10.2 Bn by the...
0 Comments 0 Shares 82 Views